by Backoffice | Mar 10, 2025 | Careers
Scientist for quality control of cell products Do you wish to explore the future of cell therapy, and do you have experience with flow cytometry and cell culturing? Who are we?Cell2Cure is a small Danish biopharmaceutical company that develops and produces...
by Backoffice | Jan 23, 2024 | Collaborations
Cell2Cure has January 2024 received a significant equity investment from Endeavour Cell ApS, to further develop our collaboration. Endeavour Cells will own 51% of the company. In addition to the invested capital the collaboration with Endeavor Cells includes milestone...
by Backoffice | Jan 4, 2024 | Collaborations
In Europe, approximately 30 million people suffer from blindness and visual impairment. Rare Eye Diseases are a major cause that can result in blindness in children and young adults and affect adults and the ageing population. Current management is expensive, has low...
by Backoffice | Nov 3, 2023 | Studies and testing
The first two children with autism spectrum disorder (ASD) and signs of leaky gut syndrome were treated October 2023 with allogeneic adipose-derived mesenchymal stem cells (C2C_ASCs) at Aalborg University Hospital without any complication. The project is a...
by Backoffice | Oct 18, 2023 | Patents
As of the 18th of September 2023, the patent secures C2Cs technological concept for industrial production, upscaling, and distribution of ASC products has been granted in Canada (Patent number: 3000912). The patent “STEM CELL THERAPY BASED ON ADIPOSE-DERIVED STEM...
